LQDA实时信号 | 通过Getagraph.com最大化利润

出售 114004 min ago

@ $14.38

发出时间: 14 Feb 2024 @ 04:39

回报率: -9.74%

上一信号: Feb 13 - 02:44

上一信号: 购买

回报率: -3.07 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 04:00):

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States...

Stats
今日成交量	460 562
平均成交量	850 100
市值	986.84M
EPS	$0 ( 2024-03-13 )
下一个收益日期	( $-0.320 ) 2024-06-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-10.73
ATR14	$0.0130 (0.10%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-19	Saggar Rajeev	Sell	1 649	Common Stock
2024-04-12	Schundler Russell	Sell	2 060	Common Stock
2024-04-12	Saggar Rajeev	Sell	1 525	Common Stock
2024-04-12	Moomaw Scott	Sell	1 585	Common Stock
2024-04-12	Kaseta Michael	Sell	3 136	Common Stock

INSIDER POWER
76.56
Last 99 transactions
Buy: 2 738 617 \| Sell: 339 337

音量相关性

長: 0.02 (neutral)

短: 0.00 (neutral)

Signal:(60.285) Neutral

Liquidia Technologies Inc 相关性

10 最正相关
ISEM	0.873
IDLB	0.86
ALOR	0.855
ACAH	0.844
HTHT	0.841
EVOP	0.839
CRNC	0.827
RCM	0.827
PATK	0.826
BSGM	0.824

10 最负相关
CMLFU	-0.877
EMBCV	-0.849
IRBT	-0.838
MAGS	-0.835
BOWXU	-0.833
HOLUU	-0.824
PROG	-0.824
ASPS	-0.821
FTOCU	-0.819
RMCF	-0.819

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Liquidia Technologies Inc 相关性 - 货币/商品

0.19
( neutral )

-0.08
( neutral )

0.00
( neutral )

0.05
( neutral )

-0.15
( neutral )

-0.01
( neutral )

Liquidia Technologies Inc 财务报表

Annual	2023
营收:	$17.49M
毛利润:	$13.42M (76.75 %)
EPS:	$-1.210

FY	2023
营收:	$17.49M
毛利润:	$13.42M (76.75 %)
EPS:	$-1.210

FY	2022
营收:	$15.94M
毛利润:	$13.08M (82.06 %)
EPS:	$-0.630

FY	2021
营收:	$12.85M
毛利润:	$9.83M (76.48 %)
EPS:	$-0.700

Financial Reports:

No articles found.

Liquidia Technologies Inc

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.